201. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice
- Author
-
Junbiao Chang, Liyun Zheng, Xuejie Zhao, Xiaorui Yang, Qingduan Wang, Xianzhen Fang, Limin Zang, Qinghua Yang, and Jing Zhao
- Subjects
DNA Replication ,Male ,HBsAg ,Hepatitis B virus ,Time Factors ,Cell Survival ,Duck hepatitis B virus ,Cytidine ,Biology ,medicine.disease_cause ,Chronic liver disease ,Virus Replication ,Antiviral Agents ,Mice ,Virology ,medicine ,Concanavalin A ,Animals ,Humans ,Benzodioxoles ,Hepatitis B e Antigens ,Pharmacology ,Liver injury ,Hepatitis B Surface Antigens ,Dose-Response Relationship, Drug ,Liver cell ,virus diseases ,Hep G2 Cells ,medicine.disease ,biology.organism_classification ,Hepatitis B ,digestive system diseases ,Ducks ,HBeAg ,Liver ,Cytoprotection ,DNA, Viral ,Chemical and Drug Induced Liver Injury ,TBIL - Abstract
Infection with hepatitis B virus (HBV) continues to be a major global cause of acute and chronic liver disease with high mortality. Herein, we examined both the anti-HBV and hepatoprotective activity of α-DDB–FNC. In human HBV-transfected liver cell line HepG2.2.15, α-DDB–FNC effectively suppressed the secretion of HBV antigens in a time and dose-dependent manner with 25.11% inhibition on HBeAg and 43.68% on HBsAg at 2.5 μM on day 9. Consistent with the HBV antigen reduction, α-DDB–FNC (2.5 μM) also reduced HBV DNA level by 77.74% extracellularly and 78.94% intracellularly on day 9. In the duck hepatitis B virus (DHBV) infected ducks, after α-DDB–FNC was given once daily for 10 days, the serum and liver DHBV DNA levels were reduced markedly with 96.81% and 97.21% at 10 mg kg −1 on day 10, respectively. In Con A-induced immunological liver-injury mice, α-DDB–FNC significantly inhibited the elevation of serum ALT, AST, TBiL and liver MDA, NO levels. Furthermore, significant improvement of the liver was observed after α-DDB–FNC treatment both in ducks and mice, as evaluated by the histopathological analysis. In conclusion, our results demonstrated that α-DDB–FNC possesses both antiviral activity against HBV and hepatoprotective effect to Con A-induced liver-injury mice.
- Published
- 2012